Pfizer and Valneva Issue Update on Phase 3 Clinical Trial Evaluating Lyme Disease Vaccine Candidate VLA15
Pfizer
FEBRUARY 16, 2023
GCP is the international ethical and scientific quality standard for clinical trials that all clinical researchers need to follow. VLA15 has demonstrated a strong immune response and satisfactory safety profile in pre-clinical and clinical studies so far. 5,6 The program was granted Fast Track designation by the U.S.
76 
Let's personalize your content